How much does one dose of Ustekinumab cost?

Ustekinumab (Ustekinumab)is indicated for the treatment of moderate to severe plaque psoriasis. It is usedin adults and children over 6 years of age whose disease has not improved or who cannot be treated with other systemic psoriasis treatments, such as cyclosporine, methotrexate, or PUVA (psoralen ultraviolet A).

Ustekinumab is also used in adults with active psoriatic arthritis (joint inflammation associated with psoriasis) when other treatments called disease-modifying antirheumatic drugs (DMARDs) have not improved the condition sufficiently. Ustekinumabcan be used alone or in combination with methotrexate (DMARD). Ustekinumab is also indicated for the treatment of moderately to severely active Crohn's disease, whose condition has not improved sufficiently with other treatments for Crohn's disease, or who are unable to receive such treatment; Ustekinumab is also indicated for the treatment of moderately to severely active ulcerative colitis, in adults whose condition has not improved sufficiently with other treatments for ulcerative colitis or who are unable to receive such treatment.

The generic drug Ustekinumab has been launched in China and is included in the medical insurance, and is only reimbursed for patients who meet the indications. The price of the 130mg/26ml intravenous injection preparation may be more than 5,000 yuan per box, and the price of the 90mg: 1.0ml*1 subcutaneous injection preparation may be more than 8,000 yuan per box. The price of the 130mg/26ml intravenous injection preparation of Ustekinumab sold overseas may be more than 2,000 US dollars per box, and the price of 45mg: 0.5ml*1 subcutaneous injection preparation per box may be more than 10,000 US dollars. There are currently no generic versions of ustekinumab produced in other overseas countries.